Page last updated: 2024-08-24

plerixafor and Pituitary Neoplasms

plerixafor has been researched along with Pituitary Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Koketshu, K; Nomura, R; Teramoto, A; Yoshida, D	1

Other Studies

1 other study(ies) available for plerixafor and Pituitary Neoplasms

Article	Year
The CXCR4 antagonist AMD3100 suppresses hypoxia-mediated growth hormone production in GH3 rat pituitary adenoma cells. Journal of neuro-oncology, 2010, Volume: 100, Issue:1 Topics: Adenoma; Animals; Benzylamines; beta Carotene; Cell Hypoxia; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Growth Hormone; Heterocyclic Compounds; Humans; Middle Aged; Oligonucleotide Array Sequence Analysis; Pituitary Neoplasms; Rats; Receptors, CXCR4; RNA, Messenger; RNA, Small Interfering; Statistics as Topic	2010

Article

Year

The CXCR4 antagonist AMD3100 suppresses hypoxia-mediated growth hormone production in GH3 rat pituitary adenoma cells.

Journal of neuro-oncology, 2010, Volume: 100, Issue:1

Topics: Adenoma; Animals; Benzylamines; beta Carotene; Cell Hypoxia; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Growth Hormone; Heterocyclic Compounds; Humans; Middle Aged; Oligonucleotide Array Sequence Analysis; Pituitary Neoplasms; Rats; Receptors, CXCR4; RNA, Messenger; RNA, Small Interfering; Statistics as Topic

2010